[Renovascular hypertension].
Ito
Sadayoshi
S
Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University School of Medicine.
D000800:Angioplasty, Balloon; D000804:Angiotensin II / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001015:Aortic Arch Syndromes / Q000150:complications; D001161:Arteriosclerosis / Q000150:complications; D003937:Diagnosis, Differential; D005352:Fibromuscular Dysplasia / Q000150:complications; D006801:Humans; D006978:Hypertension, Renovascular / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D011379:Prognosis; D012078:Renal Artery Obstruction / Q000209:etiology / Q000628:therapy; D012083:Renin / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D015607:Stents
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000804:Angiotensin II; D012964:Sodium; D012083:Renin